Various inflammatory pathways

"Various inflammatory pathways" refers to a collection of interconnected molecular signaling cascades that mediate the inflammatory response rather than a single therapeutic target. Key pathways include the NF-kappaB activation pathway, which regulates transcription of inflammatory genes; the cyclooxygenase-2 (COX-2) pathway responsible for prostanoid production; the NLRP3 inflammasome pathway that processes inflammatory cytokines; Toll-like receptor (TLR) signaling; JAK/STAT pathways downstream of cytokine receptors; and complement signaling. These pathways are activated by diverse inflammatory stimuli and produce bioactive mediators including cytokines, chemokines, and prostanoids that have pleiotropic effects across multiple cell types. Individual components within these pathways represent specific therapeutic targets, including enzymes like COX-2, transcription factors like NF-kappaB, protein complexes like the NLRP3 inflammasome, and cytokine receptors. Dysregulation of these pathways contributes to acute and chronic inflammatory diseases, atherosclerosis, cancer, autoimmune conditions, and metabolic disorders. Therapeutic strategies targeting these pathways include selective enzyme inhibitors, cytokine-blocking antibodies, receptor antagonists, small-molecule inhibitors of signaling intermediates, and pro-resolution mediators. This term should be refined to specify the particular pathway or molecular target of interest for accurate therapeutic targeting.

Other names

Inflammatory signaling pathwaysinflammatory response pathwaysinflammation pathways

Multiple mechanisms across different pathways: - Inhibition of prostanoid synthesis - Blockade of cytokine receptors - Inhibition of transcription factors (NF-kappaB, AP-1) - Inflammasome inhibition - JAK/STAT pathway inhibition - Disruption of protein-protein interactions - Caspase inhibition